cannoli: "Geraldspeak" must deal with the stock pr
Post# of 30067
Posted On: 09/26/2014 2:50:26 PM
cannoli: "Geraldspeak" must deal with the stock price because Reverse Splits and up listing are both dealing with the stock price. So when he says we are going to up list in Q4 and that he has several catalysts that will increase shareholder value so we won't have to do a massive RS....he must be talking about stock price.
If the stock price never gets above .12 cents by the end of the year....I will be wondering what led Gerald to believe that we'd be able to up list this year in the first place??
At some point, the stock price must reflect all the optimism Gerald has been saying is just around the corner....his credibility depends upon it! I don't expect the pps to be $2.00 in January 2015, but I expect it to be above .20 or .25 cents. If it isn't.....if it's still at .12..... I'll be questioning Gerald's grasp on just how far along AMBS really is and his ability to appropriately management shareholder expectations.
But I expect better! Where our pps got up to .193 cents on July 30th based on expectations of positive LymPro data being presented, I fully expect we will be above .20 or .25 cents by January 2015, after LymPro has already been launched! If you add in a MANF orphan and the beginning of the Elto trial, we should be in the .30 to .40 range by February....when we will most likely up list.
If the stock price never gets above .12 cents by the end of the year....I will be wondering what led Gerald to believe that we'd be able to up list this year in the first place??
At some point, the stock price must reflect all the optimism Gerald has been saying is just around the corner....his credibility depends upon it! I don't expect the pps to be $2.00 in January 2015, but I expect it to be above .20 or .25 cents. If it isn't.....if it's still at .12..... I'll be questioning Gerald's grasp on just how far along AMBS really is and his ability to appropriately management shareholder expectations.
But I expect better! Where our pps got up to .193 cents on July 30th based on expectations of positive LymPro data being presented, I fully expect we will be above .20 or .25 cents by January 2015, after LymPro has already been launched! If you add in a MANF orphan and the beginning of the Elto trial, we should be in the .30 to .40 range by February....when we will most likely up list.
(0)
(0)